BOSS Zhipin continued its share buyback program by spending around RMB27 million to repurchase 600,854 shares on May 26, 2026, bringing total repurchases in 2026 to over RMB1.48 billion. The company increased its buyback authorization to US$400 million through August 2027, reflecting confidence in future growth. Additionally, BOSS Zhipin plans to allocate at least 50% of adjusted net income annually from 2026 for dividends and buybacks, with flexibility to adjust based on performance and market conditions. This strategy aims to enhance shareholder returns and signal strong financial health.
Lotto.com has appointed Ruxandra Tereanu as Chief Operating Officer and Amanda Coyle as Vice President of Human Resources to strengthen its leadership team amid ongoing expansion in the US digital lottery market. Tereanu brings 13 years of experience...
Worldline has announced a conference call to discuss its H1 2026 financial results on July 30, 2026, at 6:30 pm CET. The event will be accessible via webcast, and sell-side analysts can participate in a Q&A session by pre-registering. The press relea...
Ipsen Pharma conducted a share buy-back program from July 6 to July 10, 2026, repurchasing a total of 28,541 shares. The average purchase price during this period was €166.05 per share. This buy-back activity reflects Ipsen's strategy to manage its c...
Ipsen Pharma conducted share buybacks from July 6 to July 10, 2026, purchasing a total of 28,541 shares. The average purchase price was €166.05 per share. These buybacks were made under Article 5 of the MAR regulation, indicating a structured repurch...
Barclays increased its price target for Hudbay Minerals to $32 from $30, citing strong growth prospects in copper mining. Despite a recent nearly 30% stock pullback due to market sentiment, Hudbay maintains a solid financial position with near-zero n...
